These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. Burt BM; Richards WG; Lee HS; Bartel S; Dasilva MC; Gill RR; Jaklitsch MT; Johnson BE; Swanson SJ; Bueno R; Sugarbaker DJ J Thorac Oncol; 2018 Sep; 13(9):1400-1409. PubMed ID: 29753120 [TBL] [Abstract][Full Text] [Related]
12. A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma. Arrieta O; López-Macías D; Mendoza-García VO; Bacon-Fonseca L; Muñoz-Montaño W; Macedo-Pérez EO; Muñiz-Hernández S; Blake-Cerda M; Corona-Cruz JF Cancer Chemother Pharmacol; 2014 May; 73(5):975-82. PubMed ID: 24687408 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile. Nakano T; Chahinian AP; Shinjo M; Togawa N; Tonomura A; Miyake M; Ninomiya K; Yamamoto T; Higashino K Cancer; 1999 Jun; 85(11):2375-84. PubMed ID: 10357408 [TBL] [Abstract][Full Text] [Related]
14. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma. Mense ES; Smit AAJ; Crul M; Franssen EJF J Clin Pharm Ther; 2019 Apr; 44(2):249-257. PubMed ID: 30578577 [TBL] [Abstract][Full Text] [Related]
15. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study. Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481 [TBL] [Abstract][Full Text] [Related]
16. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study. Hase T; Miyazaki M; Ichikawa K; Yogo N; Ozawa N; Hatta T; Ando M; Sato M; Kondo M; Yamada K; Hasegawa Y Int J Clin Oncol; 2020 Nov; 25(11):1928-1935. PubMed ID: 32740717 [TBL] [Abstract][Full Text] [Related]
17. Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma. Groth SS; Ripley RT J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1519-1520. PubMed ID: 32771233 [No Abstract] [Full Text] [Related]
18. Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice. Solanki MH; Chatterjee PK; Xue X; Gupta M; Rosales I; Yeboah MM; Kohn N; Metz CN Am J Physiol Renal Physiol; 2015 Jul; 309(1):F35-47. PubMed ID: 25947343 [TBL] [Abstract][Full Text] [Related]
19. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314 [TBL] [Abstract][Full Text] [Related]
20. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]